Company Update Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India The Company has received USFDA Final approval for Paroxetine Extended- Release Tablets USP 25 mg and 37.5 mg.